Quantum Surgical, a medical device company specializing in minimally invasive robotic-assisted cancer treatment, announced the ...

Johnson & Johnson MedTech announced the United States launch of the Cereglide 42 and Cereglide 57 aspiration catheters and ...

Vena Medical, which is based in Canada, announced FDA clearance for the use of its Vena MicroAngioscope system in the peripher ...

CereVasc, Inc. announced results from a prospective, multicenter, single-arm clinical study evaluating the safety and clinical ...

ABK Biomedical, Inc. announced the completion of patient enrollment in the ROUTE90 pivotal study evaluating the company’ ...

Liquet Medical Inc. announced it has received a second FDA 510(k) clearance for a new configuration of its Versus cathete ...

Sentante announced that its Sentante stroke system has been accepted into the FDA Total Product Life Cycle Advisory Program ...

A review of the hemorrhoid artery embolization technique, clinical outcomes, and patient ­selection considerations.

February 24, 2026—iVascular announced the enrollment of the first patient in the FENCO clinical study evaluating the company’s iCover ball ...

Medtronic plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted reimbursement approval fo ...

AngioDynamics, Inc. announced expanded European indications for its NanoKnife system with irreversible electroporation (IRE) ...

Bayer recently reported that its oral factor XIa inhibitor asundexian reduced the risk of recurrent ischemic stroke in patient ...